Well being Information of Monday, 6 Might 2019
Dr Anthony Nsiah-Asare
The implementation of the malaria vaccine, Mosquirix, will cut back the variety of kids who die from the illness by 40 per cent yearly.
That is in accordance with the Director Common of the Ghana Well being Service (GHS), Dr Anthony Nsiah-Asare.
In a press release issued on Friday, Dr Nsiah-Asare stated the vaccine would supply further safety of 40 per cent to kids in opposition to malaria.
Commenting on the worry that was being created by some individuals that the vaccine was able to making individuals impotent and was an agenda from the West to hurt Africans particularly Ghanaians, Dr Nsiah-Asare stated about 15,000 kids throughout seven African international locations have been taken via the primary trial section of the vaccine in 2014.
He stated in Ghana, kids in Agogo and Kintampo have been enrolled as a part of the second and third section of the trials, including that, over 3,000 kids acquired the vaccine.
He added that comply with ups on the kids didn’t reveal any main adversarial findings as was being put out.
Dr Nsiah-Asare added that the vaccine has been authorised to be used by the Meals and Medication Authority (FDA) within the implementation areas and that the FDA would proceed to watch its use as with all different vaccines.